To further understand the biological function of CDK4/6 inhibitors in the chemoresistance of SCLC, we initially discovered that CDK4/6 inhibitors cannot regulate the cell cycle in RB1‐inactivated chemotherapy‐resistant and chemosensitive SCLC cells. This evidence concerns the gene RB1 and small cell lung carcinoma.